{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T23:10:35Z","timestamp":1650409835401},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"03","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":657,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Nucl Med"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Secondary hemophagocytic lymphohistiocytosis (sHLH) is a rare disease with either an indolent or aggressive course. A 29-year-old male presented with fever, polyarthralgias, splenomegaly, retroperitoneal adenopathy, and laboratory findings consistent with Epstein\u2014Barr-mediated sHLH. Consistent with a prior survival analysis by Kim et al., splenic maximum standardized uptake value (SUVmax) &gt;2.52 and bone marrow SUVmax&gt;3.13 on 18F-fuorodeoxyglucose positron emission tomography\/computed tomography (18FDG-PET\/CT) predicted an aggressive disease with poor treatment response. Despite optimal treatment, the patient rapidly progressed to death within 3 months of symptom onset. This case underscores the potential lethal nature of sHLH, and the evolving role of 18FDG-PET\/CT in predicting disease severity and treatment response.<\/jats:p>","DOI":"10.4103\/wjnm.wjnm_73_19","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T07:48:32Z","timestamp":1599810512000},"page":"281-283","source":"Crossref","is-referenced-by-count":0,"title":["Rapidly lethal secondary hemophagocytic lymphohistiocytosis predicted by fluorodeoxyglucose positron-emission tomography\/computed tomography"],"prefix":"10.1055","volume":"19","author":[{"given":"Lovemore","family":"Makusha","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darko","family":"Pucar","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,4,19]]},"container-title":["World Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.4103\/wjnm.WJNM_73_19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T22:37:31Z","timestamp":1650407851000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.4103\/wjnm.WJNM_73_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":0,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2022,4,19]]},"published-print":{"date-parts":[[2020,7]]}},"URL":"https:\/\/doi.org\/10.4103\/wjnm.wjnm_73_19","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1450-1147","1607-3312"],"issn-type":[{"value":"1450-1147","type":"print"},{"value":"1607-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}